QQ客服 官方微博 反馈留言

	Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment
	Niu, Xiaomin; Liu, Fatao; Zhou, Yi; Zhou, Zhen; Zhou, Daizhan; Wang, Ting; Li, Ziming; Ye, Xiangyun; Yu, Yongfeng; Weng, Xiaoling
刊名	CLINICAL CANCER RESEARCH
	2017
卷号	23期号:17
ISSN号	1078-0432
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3618351
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Niu, Xiaomin,Liu, Fatao,Zhou, Yi,et al. Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment[J]. CLINICAL CANCER RESEARCH,2017,23(17).
APA	Niu, Xiaomin.,Liu, Fatao.,Zhou, Yi.,Zhou, Zhen.,Zhou, Daizhan.,...&Lu, Shun.(2017).Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment.CLINICAL CANCER RESEARCH,23(17).
MLA	Niu, Xiaomin,et al."Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment".CLINICAL CANCER RESEARCH 23.17(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。